Owkin
Owkin is a French-American AI biotech company that integrates machine learning with multimodal patient data to accelerate drug discovery, development, and diagnostics.
• Develops AI engines like TargetMATCH for therapeutic target identification and DrugMATCH for drug positioning, leveraging multimodal patient data to enhance precision medicine.
• Utilizes federated learning to train models on decentralized datasets, preserving patient privacy while enabling collaborative research across institutions.
• Offers AI-powered diagnostics such as MSIntuit CRC for colorectal cancer and Dx RlapsRisk BC for breast cancer relapse prediction, both CE-marked and deployed in clinical settings.
• Collaborates with leading pharmaceutical companies, including Sanofi and Bristol Myers Squibb, to optimize clinical trials and therapeutic development.
• Engages in open science initiatives, releasing models like Phikon for computational pathology under non-commercial licenses.